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eft Atrial Size and
ostoperative Atrial Fibrillation
he Volume of Evidence Suggests
t Is Time to Break an Old Habit*
arren J. Manning, MD, FACC,
li V. Gelfand, MD
oston, Massachusetts
eft atrial (LA) size serves as a marker of cardiovascular risk
actors, an indicator of existing cardiac disease, and a
redictor of cardiovascular outcomes (1–4), as well as the
ource of disease itself. Both LA dilation and geometric
istortion may be primary or may be secondary to left
entricular diastolic dysfunction. Therefore, it is a common
nal pathway for such diverse disease entities as hyperten-
ion, valvular heart disease, and atrial fibrillation (AF).
ontrolled animal studies have shown that AF is difficult to
nduce in very small animals and requires sufficient atrial
issue (5). Data from the population-based Framingham
nd Strong Heart studies show that increased LA size is an
ndependent risk factor for AF (2–4).
See page 779
Interest in LA size and structure as a marker of cardiac
isease has increased steadily since Feigenbaum et al. (6)
rst reported that the unidimensional M-mode LA diam-
ter correlates with angiographic LA size. Since then,
ltrasound technology has advanced, adding 2-dimensional
2D) and, more recently, real-time 3-dimensional (RT3D)
apabilities to its diagnostic armamentarium. Reflecting
hese advances, a recent position statement from the Amer-
can Society of Echocardiography supported a transition to
ore volumetric approaches to cardiac chamber quantifica-
ion (7).
In its normal, nondilated state, the LA is a spherical
tructure, and thus its volume may be well approximated
y 4/3r3, where r is a single measure of radius. How-
ver, even with minor LA distortion, the LA may enlarge
symmetrically because of the constraints of the sur-
ounding structures, such as aorta and chest wall, as well
s the eccentrically directed mitral regurgitation jets,
aking a unidimensional assessment inadequate (8). The
ssumption regarding the spherical nature of an enlarged
A may be partially tempered by using three separate
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.d
From the Cardiovascular Division, Department of Medicine, Beth Israel Deacon-
ss Medical Center and Harvard Medical School, Boston, Massachusetts.adius measurements, or by the application of a biplanar
rea method (9). To further minimize geometric assump-
ions regarding the shape of the LA, true volumetric
echniques can be used. These include cardiovascular
agnetic resonance, cardiac computed tomography, and
T3D echocardiography. Cardiovascular magnetic reso-
ance can accurately quantify LA dimensions, volume,
nd function, and can be performed with or without
ontrast agents (10,11). Cardiac computed tomography is
ccasionally used for anatomic imaging of LA around the
ime of pulmonary vein isolation (12), but exposes the
atient to ionizing radiation and nephrotoxic contrast.
hree-dimensional reconstruction of 2D images is a
eliable estimate of LA volume, and RT3D echocardiog-
aphy has proven promising in measuring LA volume
irectly (13). Although RT3D is now becoming more
idely available, 2D echocardiographic methods are still
asier to implement, and thus remain the mainstay of
iagnosis in most laboratories. Therefore, current prac-
ice of LA volume estimation by echocardiography relies
n its approximation from biplanar 2D measurements
14,15) with LA enlargement identified above a gender-
eutral, body mass index-corrected volume of 32 ml/m2
16).
Atrial arrhythmias, including AF, are encountered
requently after cardiac surgery. These arrhythmic com-
lications are associated with an increased incidence of
ystemic thromboembolism and stroke, hemodynamic
nstability, and prolonged hospital stay and increased
esource use (17). Clinical risk factors for postoperative
trial fibrillation include advanced age, obesity, mitral
alve disease, and prior history of AF or congestive heart
ailure (17,18).
The feasibility and effectiveness of prophylaxis for AF
mong patients undergoing cardiac surgery has been
reviously shown. A Cochrane review of data from 58
rials, together enrolling over 8,500 patients, identified
hat beta-adrenergic blockers, sotalol, and amiodarone, as
ell as atrial overdrive pacing, all reduce the incidence of
ostoperative AF (19). In a recent PAPABEAR (Pro-
hylactic Oral Amiodarone for the Prevention of Ar-
hythmias That Begin Early After Revascularization,
alve Replacement, or Repair) trial, perioperative amio-
arone therapy reduced the postoperative risk of atrial
achyarrhythmias by approximately 50% overall, with a
imilar benefit in patients older and younger than 65
ears (20). However, almost a week of pretreatment was
respecified in that study, which limits its applicability in
he clinical setting. In addition, the strategy of routine
reoperative administration of amiodarone exposes a
arge population of patients at variable risk for AF to
otentially serious adverse effects of this therapy. There-
ore, objective preoperative stratification or patients with
espect to their risk of developing postoperative AF is
esirable.
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Editorial Comment August 15, 2006:787–9In this issue of the Journal, Osranek et al. (21) present
he results of a prospective study of LA volume and
ncidence of postoperative AF. The LA volume was
etermined by 2D echocardiography using the biplanar
rea-length method (16,22), although using a slightly
ifferent formula from their recent publication on LA
olume and cardiovascular outcomes, in which they used
he mean of the 4-chamber and 2-chamber lengths rather
han the shortest length (1). In a cohort of 205 patients
ndergoing cardiac surgery at the Mayo Clinic, the
nvestigators show that preoperative LA volume index
as an independent predictor of postoperative AF, with
n LA volume index 32 ml/m2 conferring an almost
-fold increased risk of postoperative AF (compared with
he LA volume index 32 ml/m2). Surprisingly, amio-
arone or beta-blockade were not protective against
evelopment of postoperative AF (21). Data are also not
rovided for us to determine whether LA volume mea-
ures were superior to LA dimension or area measures in
redicting AF incidence after cardiac surgery.
Echocardiographic LA volume estimated by the bipla-
ar method has been used previously as a risk predictor of
F in older outpatients (23), as a marker of long-term
dverse events in those with lone AF (24), and as a
redictor of cardiovascular events (1). The current study
y Osranek et al. (21) builds on these previous investigations
nd provides simple means for preoperative risk stratification
f a large and common population of cardiac surgical
atients. Although the investigators have chosen to correct
A volume for body size, they have not used gender-specific
hresholds. An argument against any normalization is
nimal data supporting the theory of re-entry and AF
hat show that a minimum amount of atrial tissue is
equired (equal to the distance traveled by the cardiac
mpulse in one refractory period) and is critical to
etermination of the likelihood of re-entry (25). These
ata suggest that raw/non-normalized indexes may be
ore appropriate predictors.
Notably, in the study by Osranek et al. (21), in none of
he studied patients younger than 65 years of age and with
n LA volume 32 ml/m2 did postoperative AF develop,
dentifying a “low-risk” group in whom the risks of preop-
rative prophylaxis may in principle outweigh its benefits
21). The clinical implications of actually withholding
rophylactic beta-blockers in younger patients with normal-
ized atria before cardiac surgery will have to be assessed in
ormal clinical studies.
Old habits are often difficult to break. Parasternal LA
imension measurements have been a cornerstone of clinical
chocardiography for almost 40 years. Advances in technol-
gy facilitated area measurement more than 2 decades ago.
sranek et al. (21) have now given us another good reason
o think about the heart volumetrically, as echocardiography
dvances to the RT3D world.
1eprint requests and correspondence: Dr. Warren J. Manning,
eth Israel Deaconess Medical Center, 330 Brookline Avenue,
oston, Massachusetts 02215. E-mail: wmanning@bidmc.harvard.
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